Novo Nordisk
NVO
#50
Rank
โ‚น21.493 T
Marketcap
โ‚น4,697
Share price
-21.83%
Change (1 day)
-56.20%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2025 (TTM): โ‚น280.60

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is โ‚น290.57. In 2016 the company made an earnings per share (EPS) of โ‚น97.11.

EPS history for Novo Nordisk from 2016 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น280.60
2016โ‚น97.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น121.04-58.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,076 270.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น233.37-19.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น247.93-14.68%๐Ÿ‡ซ๐Ÿ‡ท France